Appel SH, Zhao W, Beers DR, Henkel JS: The microglial-motoneuron dialogue in ALS. Acta Myol. 2011, 30: 4-8.
PubMed Central
CAS
PubMed
Google Scholar
Pasinelli P, Brown RH: Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat Rev Neurosci. 2006, 7: 710-723.
CAS
PubMed
Google Scholar
Czaplinski A, Yen AA, Simpson EP, Appel SH: Slower disease progression and prolonged survival in contemporary patients with amyotrophic lateral sclerosis: is the natural history of amyotrophic lateral sclerosis changing?. Arch Neurol. 2006, 63: 1139-1143. 10.1001/archneur.63.8.1139.
PubMed
Google Scholar
Maruyama H, Morino H, Ito H, Izumi Y, Kato H, Watanabe Y, Kinoshita Y, Kamada M, Nodera H, Suzuki H, Komure O, Matsuura S, Kobatake K, Morimoto N, Abe K, Suzuki N, Aoki M, Kawata A, Hirai T, Kato T, Ogasawara K, Hirano A, Takumi T, Kusaka H, Hagiwara K, Kaji R, Kawakami H: Mutations of optineurin in amyotrophic lateral sclerosis. Nature. 2010, 465: 223-226. 10.1038/nature08971.
CAS
PubMed
Google Scholar
Turner MR, Hardiman O, Benatar M, Brooks BR, Chio A, de Carvalho M, Ince PG, Lin C, Miller RG, Mitsumoto H, Nicholson G, Ravits J, Shaw PJ, Swash M, Talbot K, Traynor BJ, Van den Berg LH, Veldink JH, Vucic S, Kiernan MC: Controversies and priorities in amyotrophic lateral sclerosis. Lancet Neurol. 2013, 12: 310-322. 10.1016/S1474-4422(13)70036-X.
PubMed Central
CAS
PubMed
Google Scholar
Rezania K, Yan J, Dellefave L, Deng HX, Siddique N, Pascuzzi RT, Siddique T, Roos RP: A rare Cu/Zn superoxide dismutase mutation causing familial amyotrophic lateral sclerosis with variable age of onset, incomplete penetrance and a sensory neuropathy. Amyotroph Lateral Scler Other Motor Neuron Disord. 2003, 4: 162-166. 10.1080/aml.4.3.162.166.
CAS
PubMed
Google Scholar
Lopate G, Baloh RH, Al-Lozi MT, Miller TM, Fernandes Filho JA, Ni O, Leston A, Florence J, Schierbecker J, Allred P: Familial ALS with extreme phenotypic variability due to the I113T SOD1 mutation. Amyotroph Lateral Scler. 2010, 11: 232-236. 10.3109/17482960902898069.
CAS
PubMed
Google Scholar
Mackenzie IR, Bigio EH, Ince PG, Geser F, Neumann M, Cairns NJ, Kwong LK, Forman MS, Ravits J, Stewart H, Eisen A, McClusky L, Kretzschmar HA, Monoranu CM, Highley JR, Kirby J, Siddique T, Shaw PJ, Lee VM, Trojanowski JQ: Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol. 2007, 61: 427-434. 10.1002/ana.21147.
CAS
PubMed
Google Scholar
Gurney ME: The use of transgenic mouse models of amyotrophic lateral sclerosis in preclinical drug studies. J Neurol Sci. 1997, 152 (Suppl 1): S67-S73.
CAS
PubMed
Google Scholar
Massilamany C, Gangaplara A, Kim H, Stanford C, Rathnaiah G, Steffen D, Lee J, Reddy J: Copper-zinc superoxide dismutase-deficient mice show increased susceptibility to experimental autoimmune encephalomyelitis induced with myelin oligodendrocyte glycoprotein 35–55. J Neuroimmunol. 2013, 256: 19-27. 10.1016/j.jneuroim.2012.12.004.
PubMed Central
CAS
PubMed
Google Scholar
Hadano S, Hand CK, Osuga H, Yanagisawa Y, Otomo A, Devon RS, Miyamoto N, Showguchi-Miyata J, Okada Y, Singaraja R, Figlewicz DA, Kwiatkowski T, Hosler BA, Sagie T, Skaug J, Nasir J, Brown RH, Scherer SW, Rouleau GA, Hayden MR, Ikeda JE: A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nature Genet. 2001, 29: 166-173. 10.1038/ng1001-166.
CAS
PubMed
Google Scholar
Kanekura K, Hashimoto Y, Niikura T, Aiso S, Matsuoka M, Nishimoto I: Alsin, the product of ALS2 gene, suppresses SOD1 mutant neurotoxicity through RhoGEF domain by interacting with SOD1 mutants. J Biol Chem. 2004, 279: 19247-19256. 10.1074/jbc.M313236200.
CAS
PubMed
Google Scholar
Li Q, Spencer NY, Pantazis NJ, Engelhardt JF: Alsin and SOD1(G93A) proteins regulate endosomal reactive oxygen species production by glial cells and proinflammatory pathways responsible for neurotoxicity. J Biol Chem. 2011, 286: 40151-40162. 10.1074/jbc.M111.279711.
PubMed Central
CAS
PubMed
Google Scholar
Otomo A, Kunita R, Suzuki-Utsunomiya K, Mizumura H, Onoe K, Osuga H, Hadano S, Ikeda JE: ALS2/alsin deficiency in neurons leads to mild defects in macropinocytosis and axonal growth. Biochem Biophys Res Commun. 2008, 370: 87-92. 10.1016/j.bbrc.2008.01.177.
CAS
PubMed
Google Scholar
Cai H, Shim H, Lai C, Xie C, Lin X, Yang WJ, Chandran J: ALS2/alsin knockout mice and motor neuron diseases. Neurodegener Dis. 2008, 5: 359-366. 10.1159/000151295.
PubMed Central
CAS
PubMed
Google Scholar
Gros-Louis F, Kriz J, Kabashi E, McDearmid J, Millecamps S, Urushitani M, Lin L, Dion P, Zhu Q, Drapeau P, Julien JP, Rouleau GA: Als2 mRNA splicing variants detected in KO mice rescue severe motor dysfunction phenotype in Als2 knock-down zebrafish. Hum Mol Genet. 2008, 17: 2691-2702. 10.1093/hmg/ddn171.
CAS
PubMed
Google Scholar
Chance PF, Rabin BA, Ryan SG, Ding Y, Scavina M, Crain B, Griffin JW, Cornblath DR: Linkage of the gene for an autosomal dominant form of juvenile amyotrophic lateral sclerosis to chromosome 9q34. Am J Hum Genet. 1998, 62: 633-640. 10.1086/301769.
PubMed Central
CAS
PubMed
Google Scholar
Chen Y-Z, Bennett CL, Huynh HM, Blair IP, Puls I, Irobi J, Dierick I, Abel A, Kennerson ML, Rabin BA, Nicholson GA, Auer-Grumbach M, Wagner K, De Jonghe P, Griffin JW, Fischbeck KH, Timmerman V, Cornblath DR, Chance PF: DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am J Hum Genet. 2004, 74: 1128-1135. 10.1086/421054.
PubMed Central
CAS
PubMed
Google Scholar
Moreira M-C, Klur S, Watanabe M, Nemeth AH, Le Ber I, Moniz J-C, Tranchant C, Aubourg P, Tazir M, Schöls L, Pandolfo P, Schulz JB, Pouget J, Calvas P, Shizuka-Ikeda M, Shoji M, Tanaka M, Izatt L, Shaw CE, M’Zahem A, Dunne E, Bomont P, Benhassine T, Bouslam N, Stevanin G, Brice A, Guimarães J, Mendonça P, Barbot C, Coutinho P, Sequeiros J, Dürr A, Warter JM, Koenig M: Senataxin, the ortholog of a yeast RNA helicase, is mutant in ataxia-ocular apraxia 2. Nature Genet. 2004, 36: 225-227. 10.1038/ng1303.
CAS
PubMed
Google Scholar
Grohmann K, Schuelke M, Diers A, Hoffmann K, Lucke B, Adams C, Bertini E, Leonhardt-Horti H, Muntoni F, Ouvrier R, Pfeufer A, Rossi R, Van Maldergem L, Wilmshurst JM, Wienker TF, Sendtner M, Rudnik-Schöneborn S, Zerres K, Hübner C: Mutations in the gene encoding immunoglobulin mu- binding protein 2 cause spinal muscular atrophy with respiratory distress type 1. Nat Genet. 2001, 29: 75-77. 10.1038/ng703.
CAS
PubMed
Google Scholar
Skourti-Stathaki K, Proudfoot NJ, Gromak N: Human senataxin resolves RNA/DNA hybrids formed at transcriptional pause sites to promote Xrn2-dependent termination. Mol Cell. 2011, 42: 794-805. 10.1016/j.molcel.2011.04.026.
PubMed Central
CAS
PubMed
Google Scholar
Hentati A, Ouahchi K, Pericak-Vance MA, Nijhawan D, Ahmad A, Yang Y, Rimmler J, Hung W, Schlotter B, Ahmed A, Ben Hamida M, Hentati F, Siddique T: Linkage of a commoner form of recessive amyotrophic lateral sclerosis to chromosome 15q15-q22 markers. Neurogenetics. 1998, 2: 55-60. 10.1007/s100480050052.
CAS
PubMed
Google Scholar
Stevanin G, Santorelli FM, Azzedine H, Coutinho P, Chomilier J, Denora PS, Martin E, Ouvrard-Hernandez AM, Tessa A, Bouslam N, Lossos A, Charles P, Loureiro JL, Elleuch N, Confavreux C, Cruz VT, Ruberg M, Leguern E, Grid D, Tazir M, Fontaine B, Filla A, Bertini E, Durr A, Brice A: Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosum. Nat Genet. 2007, 39: 366-372. 10.1038/ng1980.
CAS
PubMed
Google Scholar
Orlacchio A, Babalini C, Borreca A, Patrono C, Massa R, Basaran S, Munhoz RP, Rogaeva EA, St George-Hyslop PH, Bernardi G, Kawarai T: SPATACSIN mutations cause autosomal recessive juvenile amyotrophic lateral sclerosis. Brain. 2010, 133: 591-598. 10.1093/brain/awp325.
PubMed Central
PubMed
Google Scholar
Murmu RP, Martin E, Rastetter A, Esteves T, Muriel MP, El Hachimi KH, Denora PS, Dauphin A, Fernandez JC, Duyckaerts C, Brice A, Darios F, Stevanin G: Cellular distribution and subcellular localization of spatacsin and spastizin, two proteins involved in hereditary spastic paraplegia. Mol Cell Neurosci. 2011, 47: 191-202. 10.1016/j.mcn.2011.04.004.
CAS
PubMed
Google Scholar
Sapp PC, Hosler BA, McKenna-Yasek D, Chin W, Gann A, Genise H, Gorenstein J, Huang M, Sailer W, Scheffler M, Valesky M, Haines JL, Pericak-Vance M, Siddique T, Horvitz HR, Brown RH: Identification of two novel loci for dominantly inherited familial amyotrophic lateral sclerosis. Am J Hum Genet. 2003, 73: 397-403. 10.1086/377158.
PubMed Central
CAS
PubMed
Google Scholar
Lanson NA, Pandey UB: FUS-related proteinopathies: lessons from animal models. Brain Res. 2012, 1462: 3-15.
Google Scholar
Bäumer D, Hilton D, Paine SM, Turner MR, Lowe J, Talbot K, Ansorge O: Juvenile ALS with basophilic inclusions is a FUS proteinopathy with FUS mutations. Neurology. 2010, 75: 611-618. 10.1212/WNL.0b013e3181ed9cde.
PubMed Central
PubMed
Google Scholar
Doi H, Koyano S, Suzuki Y, Nukina N, Kuroiwa Y: The RNA-binding protein FUS/TLS is a common aggregate-interacting protein in polyglutamine diseases. Neurosci Res. 2010, 66: 131-133. 10.1016/j.neures.2009.10.004.
CAS
PubMed
Google Scholar
Dormann D, Rodde R, Edbauer D, Bentmann E, Fischer I, Hruscha A, Than ME, Mackenzie IR, Capell A, Schmid B, Neumann M, Haass C: ALS-associated fused in sarcoma (FUS) mutations disrupt transportin-mediated nuclear import. EMBO J. 2010, 29: 2841-2857. 10.1038/emboj.2010.143.
PubMed Central
CAS
PubMed
Google Scholar
Bosco DA, Lemay N, Ko HK, Zhou H, Burke C, Kwiatkowski TJ, Sapp P, McKenna-Yasek D, Brown RH, Hayward LJ: Mutant FUS proteins that cause amyotrophic lateral sclerosis incorporate into stress granules. Hum Mol Genet. 2010, 19: 4160-4175. 10.1093/hmg/ddq335.
PubMed Central
CAS
PubMed
Google Scholar
Haung C, Zhou H, Tong J, Chen H, Liu YJ, Wang D, Wei X, Xia XG: FUS transgenic rats develop the phenotypes of amyotropic lateral sclerosis and frontotemporal lobar degeneration. PLoS Genet. 2011, 7: e100-
Google Scholar
Chen Y, Yang M, Deng J, Chen X, Ye Y, Zhu L, Liu J, Ye H, Shen Y, Li Y, Rao EJ, Fushimi K, Zhou X, Bigio EH, Mesulam M, Xu Q, Wu JY: Expression of human FUS protein in Drosophila leads to progressive neurodegeneration. Protein Cell. 2011, 2: 477-486. 10.1007/s13238-011-1065-7.
PubMed Central
CAS
PubMed
Google Scholar
Nishimura AL, Mitne-Neto M, Silva HC, Richieri-Costa A, Middleton S, Cascio D, Kok F, Oliveira JR, Gillingwater T, Webb J, Skehel P, Zatz M: A mutation in the vesicle-trafficking protein VAPB causes late-onset spinal muscular atrophy and amyotrophic lateral sclerosis. Am J Hum Genet. 2004, 75: 822-831. 10.1086/425287.
PubMed Central
CAS
PubMed
Google Scholar
Chen HJ, Anagnostou G, Chai A, Withers J, Morris A, Adhikaree J, Pennetta G, de Belleroche JS: Characterization of the properties of a novel mutation in VAPB in familial amyotrophic lateral sclerosis. J Biol Chem. 2010, 285: 40266-40281. 10.1074/jbc.M110.161398.
PubMed Central
CAS
PubMed
Google Scholar
Teuling E, Ahmed S, Haasdijk E, Demmers J, Steinmetz MO, Akhmanova A, Jaarsma D, Hoogenraad CC: Motor neuron disease-associated mutant vesicle-associated membrane protein-associated protein (VAP) B recruits wild-type VAPs into endoplasmic reticulum-derived tubular aggregates. J Neurosci. 2007, 27: 9801-9815. 10.1523/JNEUROSCI.2661-07.2007.
CAS
PubMed
Google Scholar
Tudor EL, Galtrey CM, Perkinton MS, Lau KF, De Vos KJ, Mitchell JC, Ackerley S, Hortobágyi T, Vámos E, Leigh PN, Klasen C, McLoughlin DM, Shaw CE, Miller CC: Amyotrophic lateral sclerosis mutant vesicle-associated membrane protein-associated protein-B transgenic mice develop TAR-DNA-binding protein-43 pathology. Neuroscience. 2010, 167: 774-785. 10.1016/j.neuroscience.2010.02.035.
CAS
PubMed
Google Scholar
De Vos KJ, Mórotz GM, Stoica R, Tudor EL, Lau KF, Ackerley S, Warley A, Shaw CE, Miller CC: VAPB interacts with the mitochondrial protein PTPIP51 to regulate calcium homeostasis. Hum Mol Genet. 2012, 21: 1299-1311. 10.1093/hmg/ddr559.
PubMed Central
CAS
PubMed
Google Scholar
Qiu L, Qiao T, Beers M, Tan W, Wang H, Yang B, Xu Z: Widespread aggregation of mutant VAPB associated with ALS does not cause motor neuron degeneration or modulate mutant SOD1 aggregation and toxicity in mice. Mol Neurodegener. 2013, 8: 1-10.1186/1750-1326-8-1.
PubMed Central
CAS
PubMed
Google Scholar
Greenway MJ, Alexander MD, Ennis S, Traynor BJ, Corr B, Frost E, Green A, Hardiman O: A novel candidate region for ALS on chromosome 14q11.2. Neurology. 2004, 63: 1936-1938. 10.1212/01.WNL.0000144344.39103.F6.
CAS
PubMed
Google Scholar
Corrado L, Battistini S, Penco S, Bergamaschi L, Testa L, Ricci C, Giannini F, Greco G, Patrosso MC, Pileggi S, Causarano R, Mazzini L, Momigliano-Richiardi P, D’Alfonso S: Variations in the coding and regulatory sequences of the angiogenin (ANG) gene are not associated to ALS (amyotrophic lateral sclerosis) in the Italian population. J Neurol Sci. 2007, 258: 123-127. 10.1016/j.jns.2007.03.009.
CAS
PubMed
Google Scholar
Millecamps S, Salachas F, Cazeneuve C, Gordon P, Bricka B, Camuzat A, Guillot-Noël L, Russaouen O, Bruneteau G, Pradat PF, Le Forestier N, Vandenberghe N, Danel-Brunaud V, Guy N, Thauvin-Robinet C, Lacomblez L, Couratier P, Hannequin D, Seilhean D, Le Ber I, Corcia P, Camu W, Brice A, Rouleau G, LeGuern E, Meininger V: SOD1, ANG, VAPB, TARDBP, and FUS mutations in familial amyotrophic lateral sclerosis: genotype-phenotype correlations. J Med Genet. 2010, 47: 554-560. 10.1136/jmg.2010.077180.
CAS
PubMed
Google Scholar
Luigetti M, Lattante S, Zollino M, Conte A, Marangi G, Del Grande A, Sabatelli M: SOD1 G93D sporadic amyotrophic lateral sclerosis (SALS) patient with rapid progression and concomitant novel ANG variant. Neurobiol Aging. 1924, 2011: 32-
Google Scholar
Padhi AK, Kumar H, Vasaikar SV, Jayaram B, Gomes J: Mechanisms of loss of functions of human angiogenin variants implicated in amyotrophic lateral sclerosis. PLoS One. 2012, 7: e32479-10.1371/journal.pone.0032479.
PubMed Central
CAS
PubMed
Google Scholar
Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, Ackerley S, Durnall JC, Williams KL, Buratti E, Baralle F, de Belleroche J, Mitchell JD, Leigh PN, Al-Chalabi A, Miller CC, Nicholson G, Shaw CE: TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science. 2008, 319: 1668-1672. 10.1126/science.1154584.
CAS
PubMed
Google Scholar
Da Cruz S, Cleveland DW: Understanding the role of TDP-43 and FUS/TLS in ALS and beyond. Curr Opin Neurobiol. 2011, 21: 904-919. 10.1016/j.conb.2011.05.029.
PubMed Central
CAS
PubMed
Google Scholar
Buratti E, Baralle FE: The multiple roles of TDP-43 in pre-mRNA processing and gene expression regulation. RNA Biol. 2010, 7: 420-429. 10.4161/rna.7.4.12205.
CAS
PubMed
Google Scholar
Polymenidou M, Lagier-Tourenne C, Hutt KR, Huelga SC, Moran J, Liang TY, Ling SC, Sun E, Wancewicz E, Mazur C, Kordasiewicz H, Sedaghat Y, Donohue JP, Shiue L, Bennett CF, Yeo GW, Cleveland DW: Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat Neurosci. 2011, 14: 459-468. 10.1038/nn.2779.
PubMed Central
CAS
PubMed
Google Scholar
Tollervey JR, Curk T, Rogelj B, Briese M, Cereda M, Kayikci M, König J, Hortobágyi T, Nishimura AL, Zupunski V, Patani R, Chandran S, Rot G, Zupan B, Shaw CE, Ule J: Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat Neurosci. 2011, 14: 452-458. 10.1038/nn.2778.
PubMed Central
CAS
PubMed
Google Scholar
Higashi S, Tsuchiya Y, Araki T, Wada K, Kabuta T: TDP-43 physically interacts with amyotrophic lateral sclerosis-linked mutant CuZn superoxidedismutase. Neurochem Int. 2010, 57: 906-913. 10.1016/j.neuint.2010.09.010.
CAS
PubMed
Google Scholar
Tsao W, Jeong YH, Lin S, Ling J, Price DL, Chiang PM, Wong PC: Rodent models of TDP-43: recent advances. Brain Res. 2012, 1462: 26-39.
PubMed Central
CAS
PubMed
Google Scholar
Gendron TF, Petrucelli L: Rodent models of TDP-43 proteinopathy: investigating the mechanisms of TDP-43-mediated neurodegeneration. J Mol Neurosci. 2011, 45: 486-499. 10.1007/s12031-011-9610-7.
PubMed Central
CAS
PubMed
Google Scholar
Xu ZS: Does a loss of TDP-43 function cause neurodegeneration?. Mol Neurodegener. 2012, 7: 27-10.1186/1750-1326-7-27.
PubMed Central
CAS
PubMed
Google Scholar
Joyce PI, Fratta P, Fisher EM, Acevedo-Arozena A: SOD1 and TDP- 43 animal models of amyotrophic lateral sclerosis: recent advances in understanding disease toward the development of clinical treatments. Mamm Genome. 2011, 22: 420-448. 10.1007/s00335-011-9339-1.
CAS
PubMed
Google Scholar
Chow CY, Zhang Y, Dowling JJ, Jin N, Adamska M, Shiga K, Szigeti K, Shy ME, Li J, Zhang X, Lupski JR, Weisman LS, Meisler MH: Mutation of FIG 4 causes neurodegeneration in the pale tremor mouse and patients with CMT4J. Nature. 2007, 448: 68-72. 10.1038/nature05876.
PubMed Central
CAS
PubMed
Google Scholar
Michell RH, Dove SK: A protein complex that regulates PtdIns(3,5)P2 levels. EMBO J. 2009, 28: 86-97. 10.1038/emboj.2008.270.
PubMed Central
CAS
PubMed
Google Scholar
Zhang Y, Zolov SN, Chow CY, Slutsky SG, Richardson SC, Piper RC, Yang B, Nau JJ, Westrick RJ, Morrison SJ, Meisler MH, Weisman LS: Loss of Vac14, a regulator of the signaling lipid phosphatidylinositol 3,5-biphosphate, results in neurodegeneration in mice. Proc Natl Acad Sci USA. 2007, 104: 17518-17523. 10.1073/pnas.0702275104.
PubMed Central
CAS
PubMed
Google Scholar
Sakaguchi T, Irie T, Kawabata R, Yoshida A, Maruyama H, Kawakami H: Optineurin with amyotrophic lateral sclerosis-related mutations abrogates inhibition of interferon regulatory factor-3 activation. Neurosci Lett. 2011, 505: 279-281. 10.1016/j.neulet.2011.10.040.
CAS
PubMed
Google Scholar
Wild P, Farhan H, McEwan DG, Wagner S, Rogov VV, Brady NR, Richter B, Korac J, Waidmann O, Choudhary C, Dötsch V, Bumann D, Dikic I: Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth. Science. 2011, 333: 228-233. 10.1126/science.1205405.
PubMed Central
CAS
PubMed
Google Scholar
Korac J, Schaeffer V, Kovacevic I, Clement AM, Jungblut B, Behl C, Terzic J, Dikic I: Ubiquitin-independent function of optineurin in autophagic clearance of protein aggregates. J Cell Sci. 2013, 126: 580-592. 10.1242/jcs.114926.
PubMed Central
CAS
PubMed
Google Scholar
Johnson JO, Mandrioli J, Benatar M, Abramzon Y, Van Deerlin VM, Trojanowski JQ, Gibbs JR, Brunetti M, Gronka S, Wuu J, Ding J, McCluskey L, Martinez-Lage M, Falcone D, Hernandez DG, Arepalli S, Chong S, Schymick JC, Rothstein J, Landi F, Wang YD, Calvo A, Mora G, Sabatelli M, Monsurrò MR, Battistini S, Salvi F, Spataro R, Sola P, Borghero G, Consortium ITALSGEN, Galassi G, Scholz SW, Taylor JP, Restagno G, Chiò A, Traynor BJ: Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron. 2010, 68: 857-864. 10.1016/j.neuron.2010.11.036.
PubMed Central
CAS
PubMed
Google Scholar
Weihl CC, Temiz P, Miller SE, Watts G, Smith C, Forman M, Hanson PI, Kimonis V, Pestronk A: TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia. J Neurol Neurosurg Psychiatry. 2008, 79: 1186-1189. 10.1136/jnnp.2007.131334.
PubMed Central
CAS
PubMed
Google Scholar
Ishikawa H, Yasui K, Oketa Y, Suzuki M, Ono S: Increased expression of valosin-containing protein in the skin of patients with amyotrophic lateral sclerosis. J Clin Neurosci. 2012, 19: 522-526. 10.1016/j.jocn.2011.05.044.
CAS
PubMed
Google Scholar
Kaye FJ, Shows TB: Assignment of ubiquilin2 (UBQLN2) to human chromosome xp11: 23– > p11.1 by Gene Bridge radiation hybrids. Cytogenet Cell Genet. 2000, 89: 116-117. 10.1159/000015588.
CAS
PubMed
Google Scholar
Deng H-X, Chen W, Hong S-T, Boycott KM, Gorrie GH, Siddique N, Yang Y, Fecto F, Shi Y, Zhai H, Jiang H, Hirano M, Rampersaud E, Jansen GH, Donkervoort S, Bigio EH, Brooks BR, Ajroud K, Sufit RL, Haines JL, Mugnaini E, Pericak-Vance MA, Siddique T: Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature. 2011, 477: 211-215. 10.1038/nature10353.
PubMed Central
CAS
PubMed
Google Scholar
Daoud H, Rouleau GA: Motor neuron disease: a role for ubiquilin 2 mutations in neurodegeneration. Nat Rev Neurol. 2011, 7: 599-600. 10.1038/nrneurol.2011.163.
CAS
PubMed
Google Scholar
Al-Saif A, Al-Mohanna F, Bohlega S: A mutation in sigma-1 receptor causes juvenile amyotrophic lateral sclerosis. Ann Neurol. 2011, 70: 913-919. 10.1002/ana.22534.
CAS
PubMed
Google Scholar
Morita M, Al-Chalabi A, Andersen PM, Hosler B, Sapp P, Englund E, Mitchell JE, Habgood JJ, de Belleroche J, Xi J, Jongjaroenprasert W, Horvitz HR, Gunnarsson LG, Brown RH: A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia. Neurology. 2006, 66: 839-844. 10.1212/01.wnl.0000200048.53766.b4.
CAS
PubMed
Google Scholar
Luty AA, Kwok JB, Dobson-Stone C, Loy CT, Coupland KG, Karlström H, Sobow T, Tchorzewska J, Maruszak A, Barcikowska M, Panegyres PK, Zekanowski C, Brooks WS, Williams KL, Blair IP, Mather KA, Sachdev PS, Halliday GM, Schofield PR: Sigma nonopioid intracellular receptor 1 mutations cause frontotemporal lobar degeneration-motor neuron disease. Ann Neurol. 2010, 68: 639-649. 10.1002/ana.22274.
CAS
PubMed
Google Scholar
Hosler BA, Siddique T, Sapp PC, Sailor W, Huang MC, Hossain A, Daube JR, Nance M, Fan C, Kaplan J, Hung WY, McKenna-Yasek D, Haines JL, Pericak-Vance MA, Horvitz HR, Brown RH: Linkage of familial amyotrophic lateral sclerosis with frontotemporal dementia to chromosome 9q21-q22. JAMA. 2000, 284: 1664-1669. 10.1001/jama.284.13.1664.
CAS
PubMed
Google Scholar
DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, Nicholson AM, Finch NA, Flynn H, Adamson J, Kouri N, Wojtas A, Sengdy P, Hsiung GY, Karydas A, Seeley WW, Josephs KA, Coppola G, Geschwind DH, Wszolek ZK, Feldman H, Knopman DS, Petersen RC, Miller BL, Dickson DW, Boylan KB, Graff-Radford NR, Rademakers R: Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron. 2011, 72: 245-256. 10.1016/j.neuron.2011.09.011.
PubMed Central
CAS
PubMed
Google Scholar
van Blitterswijk M, DeJesus-Hernandez M, Rademakers R: How do C9ORF72 repeat expansions cause amyotrophic lateral sclerosis and frontotemporal dementia: can we learn from other noncoding repeat expansion disorders?. Curr Opin Neurol. 2012, 25: 689-700. 10.1097/WCO.0b013e32835a3efb.
PubMed Central
CAS
PubMed
Google Scholar
Rademakers R, Neumann M, Mackenzie IR: Advances in understanding the molecular basis of frontotemporal dementia. Nat Rev Neurol. 2012, 8: 423-434.
PubMed Central
CAS
PubMed
Google Scholar
Mori K, Weng SM, Arzberger T, May S, Rentzsch K, Kremmer E, Schmid B, Kretzschmar HA, Cruts M, Van Broeckhoven C, Haass C, Edbauer D: The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science. 2013, 339: 1335-1338. 10.1126/science.1232927.
CAS
PubMed
Google Scholar
Ash PE, Bieniek KF, Gendron TF, Caulfield T, Lin WL, Dejesus-Hernandez M, van Blitterswijk MM, Jansen-West K, Paul JW, Rademakers R, Boylan KB, Dickson DW, Petrucelli L: Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron. 2013, 77: 639-646. 10.1016/j.neuron.2013.02.004.
PubMed Central
CAS
PubMed
Google Scholar
Polymenidou M, Lagier-Tourenne C, Hutt KR, Bennett CF, Cleveland DW, Yeo GW: Misregulated RNA processing in amyotrophic lateral sclerosis. Brain Res. 2012, 1462: 3-15.
PubMed Central
CAS
PubMed
Google Scholar
Münch C, Sedlmeier R, Meyer T, Homberg V, Sperfeld AD, Kurt A, Prudlo J, Peraus G, Hanemann CO, Stumm G, Ludolph AC: Point mutations of the p150 subunit of dynactin (DCTN1) gene in ALS. Neurology. 2004, 63: 724-726. 10.1212/01.WNL.0000134608.83927.B1.
PubMed
Google Scholar
Holzbaur ELF, Tokito MK: Localization of the DCTN1 gene encoding p150 (Glued) to human chromosome 2p13 by fluorescence in situ hybridization. Genomics. 1996, 31: 398-399. 10.1006/geno.1996.0068.
CAS
PubMed
Google Scholar
Lai C, Lin X, Chandran J, Shim H, Yang WJ, Cai H: The G59S mutation in p150(glued) causes dysfunction of dynactin in mice. J Neurosci. 2007, 27: 13982-13990. 10.1523/JNEUROSCI.4226-07.2007.
PubMed Central
CAS
PubMed
Google Scholar
Laird FM, Farah MH, Ackerley S, Hoke A, Maragakis N, Rothstein JD, Griffin J, Price DL, Martin LJ, Wong PC: Motor neuron disease occurring in a mutant dynactin mouse model is characterized by defects in vesicular trafficking. J Neurosci. 2008, 28: 1997-2005. 10.1523/JNEUROSCI.4231-07.2008.
CAS
PubMed
Google Scholar
Puls I, Jonnakuty C, LaMonte BH, Holzbaur EL, Tokito M, Mann E, Floeter MK, Bidus K, Drayna D, Oh SJ, Brown RH, Ludlow CL, Fischbeck KH: Mutant dynactin in motor neuron disease. Nat Genet. 2003, 33: 455-456. 10.1038/ng1123.
CAS
PubMed
Google Scholar
Mitchell J, Paul P, Chen HJ, Morris A, Payling M, Falchi M, Habgood J, Panoutsou S, Winkler S, Tisato V, Hajitou A, Smith B, Vance C, Shaw C, Mazarakis ND, de Belleroche J: Familial amyotrophic lateral sclerosis is associated with a mutation in D-amino acid oxidase. Proc Natl Acad Sci USA. 2010, 107: 7556-7561. 10.1073/pnas.0914128107.
PubMed Central
CAS
PubMed
Google Scholar
Barker RF, Hopkinson DA: The genetic and biochemical properties of the D-amino acid oxidases in human tissues. Ann Hum Genet. 1977, 41: 27-42. 10.1111/j.1469-1809.1977.tb01959.x.
CAS
PubMed
Google Scholar
Sasabe J, Miyoshi Y, Suzuki M, Mita M, Konno R, Matsuoka M, Hamase K, Aiso S: D-amino acid oxidase controls motoneuron degeneration through D-serine. Proc Natl Acad Sci USA. 2012, 109: 627-632. 10.1073/pnas.1114639109.
PubMed Central
CAS
PubMed
Google Scholar
Hayward C, Colville S, Swingler RJ, Brock DJ: Molecular genetic analysis of the APEX nuclease gene in amyotrophic lateral sclerosis. Neurology. 1999, 52: 1899-1901. 10.1212/WNL.52.9.1899.
CAS
PubMed
Google Scholar
Tomkins J, Dempster S, Banner SJ, Cookson MR, Shaw PJ: Screening of AP endonuclease as a candidate gene for amyotrophic lateral sclerosis (ALS). Neuroreport. 2000, 11: 1695-1697. 10.1097/00001756-200006050-00020.
CAS
PubMed
Google Scholar
Vasko MR, Guo C, Thompson EL, Kelley MR: The repair function of the multifunctional DNA repair/redox protein APE1 is neuroprotective after ionizing radiation. DNA Repair (Amst). 2011, 10: 942-952. 10.1016/j.dnarep.2011.06.004.
CAS
Google Scholar
Skibinski G, Parkinson NJ, Brown JM, Chakrabarti L, Lloyd SL, Hummerich H, Nielsen JE, Hodges JR, Spillantini MG, Thusgaard T, Brandner S, Brun A, Rossor MN, Gade A, Johannsen P, Sørensen SA, Gydesen S, Fisher EM, Collinge J: Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat Genet. 2005, 37: 806-808. 10.1038/ng1609.
CAS
PubMed
Google Scholar
Cox LE, Ferraiuolo L, Goodall EF, Heath PR, Higginbottom A, Mortiboys H, Hollinger HC, Hartley JA, Brockington A, Burness CE, Morrison KE, Wharton SB, Grierson AJ, Ince PG, Kirby J, Shaw PJ: Mutations in CHMP2B in lower motor neuron predominant amyotrophic lateral sclerosis (ALS). PLoS One. 2010, 5: e9872-10.1371/journal.pone.0009872.
PubMed Central
PubMed
Google Scholar
Belly A, Bodon G, Blot B, Bouron A, Sadoul R, Goldberg Y: CHMP2B mutants linked to frontotemporal dementia impair maturation of dendritic spines. J Cell Sci. 2010, 123: 2943-2954. 10.1242/jcs.068817.
PubMed Central
CAS
PubMed
Google Scholar
Ghazi-Noori S, Froud KE, Mizielinska S, Powell C, Smidak M, Fernandez De Marco M, O’Malley C, Farmer M, Parkinson N, Fisher EM, Asante EA, Brandner S, Collinge J, Isaacs AM: Progressive neuronal inclusion formation and axonal degeneration in CHMP2B mutant transgenic mice. Brian. 2012, 135 (Pt 3): 819-832.
Google Scholar
Al-Chalabi A, Andersen PM, Nilsson P, Chioza B, Andersson JL, Russ C, Shaw CE, Powell JF, Leigh PN: Deletions of the heavy neurofilament subunit tail in amyotrophic lateral sclerosis. Hum. Molec. Genet. 1999, 8: 157-164. 10.1093/hmg/8.2.157.
CAS
PubMed
Google Scholar
Couillard-Després S, Zhu Q, Wong PC, Price DL, Cleveland DW, Julien JP: Protective effect of neurofilament heavy gene overexpression in motor neuron disease induced by mutant superoxide dismutase. Proc Natl Acad Sci USA. 1998, 95: 9626-9630. 10.1073/pnas.95.16.9626.
PubMed Central
PubMed
Google Scholar
Mersiyanova IV, Perepelov AV, Polyakov AV, Sitnikov VF, Dadali EL, Oparin RB, Petrin AN, Evgrafov OV: A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene. Am J Hum Gene. 2000, 67: 37-46. 10.1086/302962.
CAS
Google Scholar
Skvortsova V, Shadrina M, Slominsky P, Levitsky G, Kondratieva E, Zherebtsova A, Levitskaya N, Alekhin A, Serdyuk A, Limborska S: Analysis of heavy neurofilament subunit gene polymorphism in Russian patients with sporadic motor neuron disease (MND). Eur J Hum Genet. 2004, 12: 241-244. 10.1038/sj.ejhg.5201144.
CAS
PubMed
Google Scholar
Giordano G, Cole TB, Furlong CE, Costa LG: Paraoxonase 2 (PON2) in the mouse central nervous system: a neuroprotective role?. Toxicol Appl Pharmacol. 2011, 256: 369-378. 10.1016/j.taap.2011.02.014.
PubMed Central
CAS
PubMed
Google Scholar
Horner RD, Kamins KG, Feussner JR, Grambow SC, Hoff-Lindquist J, Harati Y, Mitsumoto H, Pascuzzi R, Spencer PS, Tim R, Howard D, Smith TC, Ryan MA, Coffman CJ, Kasarskis EJ: Occurrence of amyotrophic lateral sclerosis among Gulf War veterans. Neurology. 2003, 61: 742-749. 10.1212/01.WNL.0000069922.32557.CA.
CAS
PubMed
Google Scholar
Saeed M, Siddique N, Hung WY, Usacheva E, Liu E, Sufit RL, Heller SL, Haines JL, Pericak-Vance M, Siddique T: Paraoxonase cluster polymorphisms are associated with sporadic ALS. Neurology. 2006, 67: 771-776. 10.1212/01.wnl.0000227187.52002.88.
CAS
PubMed
Google Scholar
Valdmanis PN, Kabashi E, Dyck A, Hince P, Lee J, Dion P, D’Amour M, Souchon F, Bouchard JP, Salachas F, Meininger V, Andersen PM, Camu W, Dupré N, Rouleau GA: Association of paraoxonase gene cluster polymorphisms with ALS in France, Quebec, and Sweden. Neurology. 2008, 71: 514-520. 10.1212/01.wnl.0000324997.21272.0c.
CAS
PubMed
Google Scholar
Ticozzi N, LeClerc AL, Keagle PJ, Glass JD, Wills AM, van Blitterswijk M, Bosco DA, Rodriguez-Leyva I, Gellera C, Ratti A, Taroni F, McKenna-Yasek D, Sapp PC, Silani V, Furlong CE, Brown RH, Landers JE: Paraoxonase gene mutations in amyotrophic lateral sclerosis. Ann Neurol. 2010, 68: 102-107. 10.1002/ana.21993.
PubMed Central
CAS
PubMed
Google Scholar
Mizuno Y, Fujita Y, Takatama M, Okamoto K: Peripherin partially localizes in Bunina bodies in amyotrophic lateral sclerosis. J Neurol Sci. 2011, 302: 14-18. 10.1016/j.jns.2010.12.023.
CAS
PubMed
Google Scholar
Beaulieu JM, Nguyen MD, Julien JP: Late onset of motor neurons in mice overexpressing wild-type peripherin. J Cell Biol. 1999, 147: 531-544. 10.1083/jcb.147.3.531.
PubMed Central
CAS
PubMed
Google Scholar
Corrado L, Carlomagno Y, Falasco L, Mellone S, Godi M, Cova E, Cereda C, Testa L, Mazzini L, D’Alfonso S: A novel peripherin gene (PRPH) mutation identified in one sporadic amyotrophic lateral sclerosis patient. Neurobiol Aging. 2011, 32 (552): e1-e6.
PubMed
Google Scholar
Robertson J, Doroudchi MM, Nguyen MD, Durham HD, Strong MJ, Shaw G, Julien J-P, Mushynski WE: A neurotoxic peripherin splice variant in a mouse model of ALS. J Cell Biol. 2003, 160: 939-949. 10.1083/jcb.200205027.
PubMed Central
CAS
PubMed
Google Scholar
Schwab C, Yu S, McGeer EG, McGeer PL: Optineurin in Huntington’s disease intranuclear inclusions. Neurosci Lett. 2012, 506: 149-154. 10.1016/j.neulet.2011.10.070.
CAS
PubMed
Google Scholar
Xiao S, Tjostheim S, Sanelli T, McLean JR, Horne P, Fan Y, Ravits J, Strong MJ, Robertson J: An aggregate-inducing peripherin isoform generated through intron retention is upregulated in amyotrophic lateral sclerosis and associated with disease pathology. J Neurosci. 2008, 28: 1833-1840. 10.1523/JNEUROSCI.3222-07.2008.
CAS
PubMed
Google Scholar
Lefebvre S, Burlet P, Liu Q, Bertrandy S, Clermont O, Munnich A, Dreyfuss G, Melki J: Correlation between severity and SMN protein level in spinal muscular atrophy. Nat Genet. 1997, 16: 265-269. 10.1038/ng0797-265.
CAS
PubMed
Google Scholar
Veldink JH, Kalmijn S, Van der Hout AH, Lemmink HH, Groeneveld GJ, Lummen C, Scheffer H, Wokke JH, Van den Berg LH: SMN genotypes producing less SMN protein increase susceptibility to and severity of sporadic ALS. Neurology. 2005, 65: 820-825. 10.1212/01.wnl.0000174472.03292.dd.
CAS
PubMed
Google Scholar
Corcia P, Mayeux-Portas V, Khoris J, de Toffol B, Autret A, Muh JP, Camu W, Andres C, French ALS Research Group: Amyotrophic Lateral Sclerosis.Abnormal SMN1 gene copy number is a susceptibility factor for amyotrophic lateral sclerosis. Ann Neurol. 2002, 51: 243-246. 10.1002/ana.10104.
CAS
PubMed
Google Scholar
Oosthuyse B, Moons L, Storkebaum E, Beck H, Nuyens D, Brusselmans K, Van Dorpe J, Hellings P, Gorselink M, Heymans S, Theilmeier G, Dewerchin M, Laudenbach V, Vermylen P, Raat H, Acker T, Vleminckx V, Van Den Bosch L, Cashman N, Fujisawa H, Drost MR, Sciot R, Bruyninckx F, Hicklin DJ, Ince C, Gressens P, Lupu F, Plate KH, Robberecht W, Herbert JM, Collen D, Carmeliet P: Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet. 2001, 28: 131-138. 10.1038/88842.
CAS
PubMed
Google Scholar
Storkebaum E: Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat Neurosci. 2005, 8: 85-92. 10.1038/nn1360.
CAS
PubMed
Google Scholar
Brockington A: Expression of vascular endothelial growth factor and its receptors in the central nervous system in amyotrophic lateral sclerosis. J Neuropathol Exp Neurol. 2006, 65: 26-36. 10.1097/01.jnen.0000196134.51217.74.
CAS
PubMed
Google Scholar
Lambrechts D, Poesen K, Fernández-Santiago R, Al-Chalabi A, Del Bo R, Van Vught PW, Khan S, Marklund SL, Brockington A, van Marion I, Anneser J, Shaw C, Ludolph AC, Leigh NP, Comi GP, Gasser T, Shaw PJ, Morrison KE, Andersen PM, Van den Berg LH, Thijs V, Siddique T, Robberecht W, Carmeliet P: Meta-analysis of vascular endothelial growth factor variations in amyotrophic lateral sclerosis: increased susceptibility in male carriers of the -2578AA genotype. J Med Genet. 2009, 46: 840-846. 10.1136/jmg.2008.058222.
CAS
PubMed
Google Scholar
Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C, Snowden J, Adamson J, Sadovnick AD, Rollinson S, Cannon A, Dwosh E, Neary D, Melquist S, Richardson A, Dickson D, Berger Z, Eriksen J, Robinson T, Zehr C, Dickey CA, Crook R, McGowan E, Mann D, Boeve B, Feldman H, Hutton M: Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature. 2006, 442: 916-919. 10.1038/nature05016.
CAS
PubMed
Google Scholar
Schymick JC, Yang Y, Andersen PM, Vonsattel JP, Greenway M, Momeni P, Elder J, Chiò A, Restagno G, Robberecht W, Dahlberg C, Mukherjee O, Goate A, Graff-Radford N, Caselli RJ, Hutton M, Gass J, Cannon A, Rademakers R, Singleton AB, Hardiman O, Rothstein J, Hardy J, Traynor BJ: Progranulin mutations and amyotrophic lateral sclerosis or amyotrophic lateral sclerosis-frontotemporal dementia phenotypes. J Neurol Neurosurg Psychiatry. 2007, 78: 754-756.
PubMed Central
CAS
PubMed
Google Scholar
Elden AC, Kim HJ, Hart MP, Chen-Plotkin AS, Johnson BS, Fang X, Armakola M, Geser F, Greene R, Lu MM, Padmanabhan A, Clay-Falcone D, McCluskey L, Elman L, Juhr D, Gruber PJ, Rüb U, Auburger G, Trojanowski JQ, Lee VM, Van Deerlin VM, Bonini NM, Gitler AD: Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS. Nature. 2010, 466: 1069-1075. 10.1038/nature09320.
PubMed Central
CAS
PubMed
Google Scholar
Ralser M, Nonhoff U, Albrecht M, Lengauer T, Wanker EE, Lehrach H, Krobitsch S: Ataxin-2 and huntingtin interact with endophilin-A complexes to function in plastin-associated pathways. Hum Molec Genet. 2005, 14: 2893-2909. 10.1093/hmg/ddi321.
CAS
PubMed
Google Scholar